Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fucoidan is a long-chain, sulfated polysaccharide predominantly found in the cell walls of various species of brown algae. It exhibits diverse bioactivities including anti-cancer, anti-inflammatory, immunomodulatory, antiviral, anticoagulant/antithrombotic, antioxidant, and neuroprotective effects. These effects have been demonstrated in vitro, in animal models, and some early-phase human studies. Its activity often depends on molecular weight and degree/patterns of sulfation.
Inhibition of matrix metalloproteinases (MMPs) via suppression of NF-kB signaling pathways; Suppression of inflammatory mediators such as cyclooxygenase‐2 (COX‐2) and nitric oxide synthase; Modulation of immune responses by affecting cytokine production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fucoidan.